Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|November 23, 2017
Critical Role for Very-Long Chain Sphingolipids in Invariant Natural Killer T Cell Development and HomeostasisAshish Saroha, Yael Pewzner-Jung, Natalia S Ferreira, et al.
Life Science Alliance|May 28, 2024
Dual neutrophil subsets exacerbate or suppress inflammation in tuberculosis via IL-1β or PD-L1Emilie Doz-Deblauwe, Badreddine Bounab, Florence Carreras, et al.
Glycoconjugate Journal|June 18, 2009
Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophagesFrançois Trottein, Lana Schaffer, Stoyan Ivanov, et al.
The Journal of Biological Chemistry|February 2, 2012
Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damagesChristophe Paget, Stoyan Ivanov, Josette Fontaine, et al.
The Journal of Experimental Medicine|September 4, 2020
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patientsYouenn Jouan, Antoine Guillon, Loïc Gonzalez, et al.
Mucosal Immunology|October 20, 2019
Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell responseMaya Hassane, Youenn Jouan, Florent Creusat, et al.
Cell Reports|September 9, 2020
High Dimensional Single-Cell Analysis Reveals iNKT Cell Developmental Trajectories and Effector Fate DecisionThomas Baranek, Kevin Lebrigand, Carolina de Amat Herbozo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2011
Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumoniaChristophe Paget, Stoyan Ivanov, Josette Fontaine, et al.
Nature Immunology|February 1, 2022
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responsesMélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, et al.
Blood|August 31, 2012
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphomaStephen R Mattarollo, Alison C West, Kim Steegh, et al.
Pageof 7